Combination therapy using Cel-CSO/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K/AKT/NF-κB/HIF-1α pathway
Article in Drug Delivery and Translational Research (June 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Article in Drug Delivery and Translational Research (June 2024)
Article in Wiley Interdisciplinary Reviews - RNA (September 2023)
Article in Genes & Diseases (August 2023)